Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Planned maintenance
A system upgrade is planned for 10/12-2024, at 12:00-13:00. During this time DiVA will be unavailable.
Change search
Refine search result
12 1 - 50 of 71
CiteExportLink to result list
Permanent link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Rows per page
  • 5
  • 10
  • 20
  • 50
  • 100
  • 250
Sort
  • Standard (Relevance)
  • Author A-Ö
  • Author Ö-A
  • Title A-Ö
  • Title Ö-A
  • Publication type A-Ö
  • Publication type Ö-A
  • Issued (Oldest first)
  • Issued (Newest first)
  • Created (Oldest first)
  • Created (Newest first)
  • Last updated (Oldest first)
  • Last updated (Newest first)
  • Disputation date (earliest first)
  • Disputation date (latest first)
  • Standard (Relevance)
  • Author A-Ö
  • Author Ö-A
  • Title A-Ö
  • Title Ö-A
  • Publication type A-Ö
  • Publication type Ö-A
  • Issued (Oldest first)
  • Issued (Newest first)
  • Created (Oldest first)
  • Created (Newest first)
  • Last updated (Oldest first)
  • Last updated (Newest first)
  • Disputation date (earliest first)
  • Disputation date (latest first)
Select
The maximal number of hits you can export is 250. When you want to export more records please use the Create feeds function.
  • 1.
    Al Ani, Amer
    et al.
    Ajman Univ, Coll Med, Ajman, U Arab Emirates..
    Tahtamoni, Rafeef
    Sharjah Univ, Coll Med, Sharjah, U Arab Emirates..
    Mohammad, Yara
    Sharjah Univ, Coll Med, Sharjah, U Arab Emirates..
    Al-Ayoubi, Fawzi
    Sheikh Khalifa Med City, Ajman, U Arab Emirates..
    Haider, Nadeem
    Sheikh Khalifa Med City, Ajman, U Arab Emirates..
    Al-Mashhadi, Ammar
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Pediatric Surgery. Sheikh Khalifa Med City Ajman, Ajman, U Arab Emirates..
    Impacts of severity of Covid-19 infection on the morbidity and mortality of surgical patients2022In: Annals of Medicine and Surgery, E-ISSN 2049-0801, Vol. 79, article id 103910Article in journal (Refereed)
    Abstract [en]

    Introduction: One of the challenges of surgery on patients with active SARS-CoV-2(severe acute respiratory syndrome coronavirus 2) infection is the increased risk of postoperative morbidity and mortality. Aim: This study will describe and compare the postoperative morbidity and mortality in asymptomatic patients or those with mild infection with those with severe COVID-19 infection undergoing elective or and emergency surgery. Materials and methods: This is a retrospective study of 37 COVID19 patients who had the infection 7 days prior to and 30 days after emergency or elective surgery. Patients were divided to two groups. Group1: the asymptomatic or those with mild infection that is diagnosed just before surgery (14 patients). Group 2: those who were admitted to the hospital because of severe COVID-19 and were operated for COVID-19 related complications (23 patients). Morbidity and mortality of both groups was studied. Results: There was no significant difference in gender between the two groups. There were 5 females (2 in group 1, and 3 in group 2) and 32 males (12 in group 1, and 20 in group 2). Mean age for all patients was 49.8years (38 for group 1 and 57 for group2). Median age for all patients was 50 years (37.5 for group 1 and 57 years for group 2). Sepsis developed in 7 patients (1 patient in group 1 and in 6 patients in group 2). Statistically there was no significant difference in occurrence of sepsis between the two groups. There was a significant difference in the intensive care stay between the two groups (higher in group 2). Four deaths were reported in group 1 and fourteen in group 2. Eighteen out of thirty-seven patients died. Conclusion: Severity of COVID-19 infection will prolong the hospitalization and ICU stay in surgical patients with no significant effect on mortality.

  • 2.
    Al-Mashhadi, Ammar
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Häggman, Michael
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Urology.
    Läckgren, Göran
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Ladjevardi, Sam
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Urology.
    Nevéus, Tryggve
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Paediatric Inflammation Research.
    Stenberg, Arne
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Persson, A. Erik G.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology.
    Carlstrom, Mattias
    Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.
    Changes of arterial pressure following relief of obstruction in adults with hydronephrosis2018In: Upsala Journal of Medical Sciences, ISSN 0300-9734, E-ISSN 2000-1967, Vol. 123, no 4, p. 216-224Article in journal (Refereed)
    Abstract [en]

    Background: As much as 20% of all cases of hypertension are associated with kidney malfunctions. We have previously demonstrated in animals and in pediatric patients that hydronephrosis causes hypertension, which was attenuated by surgical relief of the ureteropelvic junction (UPJ) obstruction. This retrospective cohort study aimed to investigate: (1) the proposed link between hydronephrosis, due to UPJ obstruction, and elevated arterial pressure in adults; and (2) if elevated blood pressure in patients with hydronephrosis might be another indication for surgery.

    Materials and methods: Medical records of 212 patients undergoing surgical management of hydronephrosis, due to UPJ obstruction, between 2000 and 2016 were assessed. After excluding patients with confounding conditions and treatments, paired arterial pressures (i.e. before/after surgery) were compared in 49 patients (35 years old; 95% CI 29–39). Split renal function was evaluated by using mercaptoacetyltriglycine (MAG3) renography before surgical management of the hydronephrotic kidney.

    Results: Systolic (−11 mmHg; 95% CI 6–15 mmHg), diastolic (−8 mmHg; 95% CI 4–11 mmHg), and mean arterial (-9 mmHg; 95% CI 6–12) pressures were significantly reduced after relief of the obstruction (p < 0.001). Split renal function of the hydronephrotic kidney was 39% (95% CI 37–41). No correlations were found between MAG3 and blood pressure level before surgery or between MAG3 and the reduction of blood pressure after surgical management of the UPJ obstruction.

    Conclusions: In adults with hydronephrosis, blood pressure was reduced following relief of the obstruction. Our findings suggest that elevated arterial pressure should be taken into account as an indication to surgically correct hydronephrosis.

    Download full text (pdf)
    FULLTEXT01
  • 3.
    Al-Mashhadi, Ammar Nadhom Farman
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Dukic, Milena
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology.
    Engstrand Lilja, Helene
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Rhabdomyomatous mesenchymal hamartoma presenting in a child as a perineal mass2019In: Journal of Pediatric Surgery Case Reports, E-ISSN 2213-5766, Vol. 47, article id 101242Article in journal (Refereed)
    Abstract [en]

    Rhabdomyomatous mesenchymal hamartoma (RMH) is a rare hamartomatous lesion in the dermis and subcutaneous tissue. It is mostly found in the face and neck region of children. We report a case of solitary RMH located in the perineum of an 8-month-old boy. Microscopic examination of specimen showed a disordered collection of mature adipose tissue, skeletal muscle, adnexal elements and nerve bundles, and immunohistochemistry confirmed a RMH. This case emphasizes the possibility of RMH in the perineum of the children. Even if RMH is a rare condition in the perineum it should be considered as a differential diagnosis of a perineal mass in children.

    Download full text (pdf)
    FULLTEXT01
  • 4.
    Andersson, Björn
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Tan, Ee Phie
    Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA..
    McGreal, Steven R.
    Kansas Univ, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA..
    Apte, Udayan
    Kansas Univ, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA..
    Hanover, John A.
    NIDDK, NIH, Bethesda, MD 20892 USA..
    Slawson, Chad
    Kansas Univ, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA..
    Lagerlöf, Olof
    Umeå Univ, Dept Clin Sci, S-90187 Umeå, Sweden.;Umeå Univ, Dept Integrat Med Biol, S-90187 Umeå, Sweden.;Umeå Univ, Wallenberg Ctr Mol Med, S-90187 Umeå, Sweden..
    O-GlcNAc cycling mediates energy balance by regulating caloric memory2021In: Appetite, ISSN 0195-6663, E-ISSN 1095-8304, Vol. 165, article id 105320Article in journal (Refereed)
    Abstract [en]

    Caloric need has long been thought a major driver of appetite. However, it is unclear whether caloric need regulates appetite in environments offered by many societies today where there is no shortage of food. Here we observed that wildtype mice with free access to food did not match calorie intake to calorie expenditure. While the size of a meal affected subsequent intake, there was no compensation for earlier under- or over-consumption. To test how spontaneous eating is subject to caloric control, we manipulated O-linked beta-N-acetylglucosamine (OGlcNAc), an energy signal inside cells dependent on nutrient access and metabolic hormones. Genetic and pharmacological manipulation in mice increasing or decreasing O-GlcNAcylation regulated daily intake by controlling meal size. Meal size was affected at least in part due to faster eating speed. Without affecting meal frequency, O-GlcNAc disrupted the effect of caloric consumption on future intake. Across days, energy balance was improved upon increased O-GlcNAc levels and impaired upon removal of O-GlcNAcylation. Rather than affecting a perceived need for calories, O-GlcNAc regulates how a meal affects future intake, suggesting that OGlcNAc mediates a caloric memory and subsequently energy balance.

    Download full text (pdf)
    fulltext
  • 5.
    Angsten, Gertrud
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Gustafson, Elisabet
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Dahl, Niklas
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Medicinsk genetik och genomik.
    Christofferson, Rolf H.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Resolution of infantile intestinal pseudo-obstruction in a boy2017In: Journal of Pediatric Surgery Case Reports, E-ISSN 2213-5766, Vol. 24, p. 28-34Article in journal (Refereed)
    Abstract [en]

    A term boy with spontaneous passage of meconium exhibited episodes of abdominal distension and diarrhea. Due to failure to thrive and suspicion of Hischsprung's disease he was referred to our university hospital at five months of age. Rectal biopsies were normal. Laparotomy revealed dilation of the small bowel and colon without any mechanical obstruction. Full thickness bowel biopsies were taken and a loop ileostomy was constructed. Histopathology revealed fibrosing myopathy, Cajal cell hypertrophy, and neuronal degeneration in both the large and small bowel. The small bowel showed mastocytosis without inflammation. A central venous catheter was placed for vascular access, replaced three times and later switched to a subcutaneous venous port. Catheters were locked after use with vancomycin-heparin and later taurolidine. The individually tailored home parenteral nutrition contained unsaturated fatty acid lipids to reduce cholestasis. Initial insufficient growth was improved after correction of partial parenteral nutrition based on a metabolic balance study. The ileostomy was revised once and finally taken down at 11 years of age following one year without parenteral support. At follow-up at 13 years of age he has episodes of moderate abdominal pain and has entered puberty and reports a high quality of life. (C) 2017 The Authors. Published by Elsevier Inc.

    Download full text (pdf)
    fulltext
  • 6.
    Arana Håkanson, Cecilia
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Fredriksson, Fanny
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery. Section of Pediatric Surgery, Uppsala University Children's Hospital.
    Engstrand Lilja, Helene
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery. Section of Pediatric Surgery, Uppsala University Children's Hospital.
    Adhesive small bowel obstruction after appendectomy in children: Laparoscopic versus open approach2020In: Journal of Pediatric Surgery, ISSN 0022-3468, E-ISSN 1531-5037, Vol. 55, no 11, p. 2419-2424Article in journal (Refereed)
    Abstract [en]

    Background

    The aims of this study were to compare the incidence of small bowel obstruction (SBO) requiring laparotomy after laparoscopic appendectomy (LA) and open appendectomy (OA) in children and to identify risk factors for SBO.

    Methods

    Medical records of patients who underwent appendectomy from 2000 to 2014 at our department of Pediatric Surgery were reviewed. Risk factors were analyzed using Cox proportional hazard regression.

    Results

    Totally 619 out of 840 patients were included. OA was performed in 474 (76.6%), LA in 130 patients (21%), and 15 (2.4%) were converted from LA to OA. Age, sex and proportion of perforated appendicitis were comparable in the LA and OA groups. Median follow-up time was 11.4 years (2.6–18.4). The incidence of SBO after LA was 1.5%, after OA 1.9% and in the converted group 6.7% (p = 0.3650). There were no significant differences in the incidence of postoperative intraabdominal abscess, wound infection or length of stay between LA and OA. Perforation and postoperative intra-abdominal abscess were identified as risk factors with 9.03 (p < 0.001) and 6.98 (p = 0.004) times higher risk of SBO, respectively.

    Conclusions

    The risk for SBO after appendectomy in children was significantly related to perforated appendicitis and postoperative intra-abdominal abscess and not to the surgical approach.

    Level of Evidence

    Level III.

    Download full text (pdf)
    fulltext
  • 7.
    Arana Håkanson, Cecilia
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Fredriksson, Fanny
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery. Univ Childrens Hosp, Dept Pediat Surg, Uppsala, Sweden..
    Engstrand Lilja, Helene
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery. Univ Childrens Hosp, Dept Pediat Surg, Uppsala, Sweden..
    Attention deficit hyperactivity disorder and educational level in adolescent and adult individuals after anesthesia and abdominal surgery during infancy2020In: PLOS ONE, E-ISSN 1932-6203, Vol. 15, no 10, article id e0240891Article in journal (Refereed)
    Abstract [en]

    Aim: Several studies in animal models have found that exposure to anesthetics in early life can cause cognitive dysfunction. Human studies show conflicting results and studies of cognitive function after anesthesia and neonatal surgery are scarce. The aim of this study was to investigate whether exposure to anesthesia and abdominal surgery during infancy was associated with cognitive dysfunction from the perspective of educational level, disposable income and attention deficit hyperactivity disorders (ADHD) in adolescent and adult individuals.

    Methods: A cohort study with patients born 1976 to 2002 that underwent abdominal surgery during infancy at a pediatric surgical center were matched by age, sex, and gestational age to ten randomly selected individuals from the Swedish Medical Birth Register. Individuals with chromosomal aberrations were excluded. Data on highest level of education and annual disposable income were attained from Statistics Sweden and the diagnosis of ADHD were retrieved from the Swedish National Patient Register.

    Results: 485 individuals and 4835 controls were included. Median gestational age was 38 weeks (24-44) and median age at surgery was seven days (0-365). Three hundred sixty-six individuals (70.0%) underwent surgery during the neonatal period (< 44 gestational weeks). Median operating time was 80 minutes (10-430). The mean age at follow-up was 28 years. Fisher's exact test for highest level of education for the exposed and unexposed groups were respectively: university 35% and 33%, upper secondary 44% and 47%, compulsory 21% and 20% (p = 0.6718). The median disposable income was 177.7 versus 180.9 TSEK respectively (p = 0.7532). Exposed individuals had a prevalence of ADHD of 5.2% and unexposed 4.4% (p = 0.4191).

    Conclusions: This study shows that exposure to anesthesia and abdominal surgery during infancy is not associated with cognitive dysfunction from the perspective of educational level, disposable income and ADHD in adolescent and adult individuals. Further studies in larger cohorts at earlier gestational ages are needed to verify these findings.

    Download full text (pdf)
    FULLTEXT01
  • 8.
    Chamorro, Clara I.
    et al.
    Karolinska Inst, Dept Womens & Childrens Hlth, Ctr Mol Med, Stockholm, Sweden.;Copenhagen Univ Hosp, Rigshosp, Surg Clin C, Dept Pediat Surg, Copenhagen, Denmark..
    Engberg, Gisela Reinfeldt
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery. Karolinska Inst, Dept Womens & Childrens Hlth, Ctr Mol Med, Stockholm, Sweden..
    Fossum, Magdalena
    Karolinska Inst, Dept Womens & Childrens Hlth, Ctr Mol Med, Stockholm, Sweden.;Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Dept Highly Specialized Pediat Surg & Med, Stockholm, Sweden.;Copenhagen Univ Hosp, Rigshosp, Surg Clin C, Dept Pediat Surg, Copenhagen, Denmark.;Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark..
    Molecular and histological studies of bladder wound healing in a rodent model2020In: Wound Repair and Regeneration, ISSN 1067-1927, E-ISSN 1524-475X, Vol. 28, no 3, p. 293-306Article in journal (Refereed)
    Abstract [en]

    The field of regenerative medicine encounters different challenges. The success of tissue-engineered implants is dependent on proper wound healing. Today, the process of normal urinary bladder wound healing is poorly characterized. We aspired to explore and elucidate the natural response to injury in an in vivo model in order to further optimize tissue regeneration in future studies. In this study, we aimed to characterize histological and molecular changes during normal healing in a rat model by performing a standardized incisional wound followed by surgical closure. We used a rodent model (n = 40) to follow the healing process in the urinary bladder for 28 days. Surgical exposure of the bladder without incision (n = 40) was performed in controls. Histological characterization and western blot analyses of proteins was carried out using specific staining and markers for inflammation, proliferation, angiogenesis, and tissue maturation. For the molecular characterization of gene expression total RNA was collected for RT2-PCR in wound healing pathway arrays. Analysis of histology revealed distinct, but overlapping, phases of healing with a local inflammatory response (days 1-8) simultaneous with a rapid formation of granulation tissue and proliferation (days 2-8). We also identified significant changes in gene expression related to inflammation, proliferation, and extracellular matrix formation. Healing of an incisional wound in a rodent urinary bladder demonstrated that all the classical phases of wound healing: hemostasis, inflammation, proliferation followed by tissue maturation were present. Our data suggest that the bladder and the skin share similar molecular signaling during wound healing, although we noted differences in the duration of each phase compared to previous studies in rat skin. Further studies will address whether our findings can be extrapolated to the human bladder.

    Download full text (pdf)
    fulltext
  • 9.
    Danielson, Johan
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Karlbom, Urban
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Colorectal Surgery.
    Graf, Wilhelm
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Colorectal Surgery.
    Wester, Tomas
    Karolinska Univ Hosp, Dept Pediat Surg, Stockholm, Sweden;Karolinska Inst, Stockholm, Sweden.
    Persistent fecal incontinence into adulthood after repair of anorectal malformations2019In: International Journal of Colorectal Disease, ISSN 0179-1958, E-ISSN 1432-1262, Vol. 34, no 3, p. 551-554Article in journal (Refereed)
    Abstract [en]

    Purpose: Persistent fecal incontinence beyond childhood is common in ARM patients. The aim of this study was to analyze a consecutive series of adult patients with persistent incontinence, establish the causes, and evaluate whether further treatment could be offered. Methods: Forty-four adult ARM patients with reported incontinence were invited. Eighteen patients (11 males, median age 40.5 years, range 18-50 years) accepted and underwent clinical examination, rectoscopy, and 3D-ultrasound. Five had previously been treated with secondary surgery to improve continence. Results: Seventeen of the 18 patients had abnormal findings at examination. Eight patients had obstruction of the reconstructed anus. Eleven patients had sacral deformities. Nine patients had a defect in the external anal sphincter and nine patients could not contract the sphincter on demand. Five patients had significant prolapse of mucosa. In one patient, the neoanus was totally misplaced, one patient had a rectovaginal fistula, and one patient had short bowel syndrome due to several small bowel resections. Ten patients were offered conservative and five surgical treatment. Conclusions: This case series of adults shows that a majority of the patients can be offered further treatment. This indicates a need for structured follow-up of ARM patients into adulthood.

    Download full text (pdf)
    FULLTEXT01
  • 10.
    Danielson, Johan
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Pediatric Surgery.
    Karlbom, Urban
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Upper Abdominal Surgery.
    Sonesson, Ann-Cathrine
    Graf, Wilhelm
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Colorectal Surgery. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Upper Abdominal Surgery.
    Change in Deferring Time Correlate to Improved Female Sexual Function after Anal Sphincter Repair: A Prospective Study2020In: Open Journal of Obstetrics and Gynecology, ISSN 2160-8792, E-ISSN 2160-8806, Vol. 10, no 05, p. 729-737Article in journal (Refereed)
    Abstract [en]

    Background: Many women suffer from sexual problems after anal sphincter tears due to obstetric trauma. 

    Aim: The study aimed to assess changes in sexual function after anal sphincter repair. 

    Methods: The study was a non-randomized prospective observational cohort study. Inclusion of the study was done at the University Hospital, Uppsala, Sweden, between 2002 and 2007. Thirty-nine consecutive female patients admitted for anal sphincter repair were invited to the study. Twenty patients accepted and were included, four were lost to follow up and one was unevaluable (due to the formation of a stoma) leaving a study group of 15 patients. The patients were assessed with questionnaires before surgery and at three and 12 months after surgery. 

    Outcomes: Change in reported sexual activity and dyspareunia. 

    Results: Before surgery, 12/15 patients reported that their sexual life was impaired due to anal incontinence. The corresponding figure at 12 months was 9/15 (p = 0.43). Three patients remained sexually inactive throughout the study, five patients increased their sexual activity and one had decreased activity. Out of the 12 who were active, four stated dyspareunia at baseline, and only one reported dyspareunia at 12 months. The mean Miller incontinence scores at baseline and 12 months were 10.1 and 8.7, respectively. The change in incontinence score did not differ between those with decreased, stable or increased sexual activity. However, there was a definite correlation (r = 0.54 - 0.60, p < 0.05) between change in sexual function and deferring time for stool. 

    Clinical Implications: Operative management of anal sphincter tears alone is not curative for sexual problems due to anal incontinence but can be a part of the treatment. 

    Strengths and Limitations: The study is a prospective study of sexual function. The limitations are that the questionnaires were not validated due to lack of such questionnaires at the time of the study and that the study population is quite small. 

    Conclusion: Patients with a sphincter injury and fecal incontinence often have an impaired sexual function. Increased deferring time for stools after surgery increases the likelihood of improved sexual function.

    Download full text (pdf)
    fulltext
  • 11.
    Danielson, Johan
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Karlbom, Urban
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Upper Abdominal Surgery.
    Wester, Tomas
    Karolinska Univ Hosp, Dept Pediat Surg, Stockholm, Sweden.;Karolinska Inst, Stockholm, Sweden..
    Graf, Wilhelm
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Upper Abdominal Surgery.
    Injectable bulking treatment of persistent fecal incontinence in adult patients after anorectal malformations2020In: Journal of Pediatric Surgery, ISSN 0022-3468, E-ISSN 1531-5037, Vol. 55, no 3, p. 397-402Article in journal (Refereed)
    Abstract [en]

    Background/Purpose: Injectable bulking therapy has emerged as a treatment for fecal incontinence (IT, however there are no studies including adult patients with anorectal malformations (ARM). This study aimed to evaluate non-animal stabilized hyaluronic add with dextranomer (NASHA/Dx) for the treatment of adult ARM patients with persistent FI.

    Methods: Seven adults with ARM and incontinence to loose stool at least once weekly and without rectal or mucosal prolapse were treated with anal NASHA/Dx injection. They were evaluated preoperatively, at 6 and 18 months with a bowel function questionnaire and a 2-week bowel diary as well as FTQL and SF-36 quality of life questionnaires.

    Results: Before treatment, the mean number of incontinence episodes over 2 weeks was 20.7 (median 16, range 8-52). At 6 months, the corresponding figures were 53 (median 4, range 0-19, p = 0.018), and at 18 months the figures were 4.3 (median 2, range 1-20,p = 0.018). An improved physical function in SF-36 from 74.3 at baseline to 86.4 at 6 months was noted (p = 0.04). No serious adverse events occurred.

    Conclusions: NASHA/Dx is a promising treatment option for selected adult patients with persistent Ft after ARM. Longer follow up of larger patient series and studies on patients in adolescence is needed. 

  • 12.
    Danielson, Johan
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Karlbom, Urban
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences.
    Wester, Tomas
    Astrid Lindgren Childrens Hosp, Dept Pediat Surg, Stockholm, Sweden.
    Graf, Wilhelm
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences.
    Long-Term Outcome after Dynamic Graciloplasty for Treatment of Persistent Fecal Incontinence in Patients with Anorectal Malformations2019In: European journal of pediatric surgery, ISSN 0939-7248, E-ISSN 1439-359X, Vol. 29, no 3, p. 276-281Article in journal (Refereed)
    Abstract [en]

    Purpose Dynamic graciloplasty (DGP) has been used to treat severe fecal incontinence since the 1980s. Previous studies have shown an inferior outcome in patients with anorectal malformations (ARMs). Our experience has been that DGP has been appreciated by ARM -patients. The objective of the study was to evaluate the long-term outcome of DGP in our patients with ARM compared with patients with other underlying conditions. Materials and Methods Twenty-three patients operated with DGP at our institution from 1996 to 2010 were sent validated bowel function and quality of life questionnaires. Eighteen of 23 responded. Seven had ARM and 11 had other etiologies of fecal incontinence. The mean follow-up time was 11.6 years (range, 5-17). Results Four of 7 of the patients with ARM and 8 of 11 of patients with other etiologies used their implants at follow-up. The Miller incontinence score was slightly higher for patients with ARMs, but they had less constipation and higher Fecal Incontinence Quality of Life (FIQL)- and 36-Item Short Form Health Survey (SF-36) scores. None of the differences were statistically significant. Conclusion This study cannot confirm earlier reports in which DGP has an inferior outcome in patients with ARM. We therefore believe that the procedure should remain a treatment option for selected patients.

  • 13.
    Danielson, Johan
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Pediatric Surgery.
    Pakkasjärvi, Niklas
    Department of Pediatric Surgery, Akademiska Sjukhuset, Uppsala, Sweden; Turku Univ Hosp, Childrens Hosp, Dept Pediat Surg, Turku, Finland.
    Högberg, Niclas
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Pediatric Surgery.
    Percutaneous Hernia Repair in Children: Safe to introduce2021In: Scandinavian Journal of Surgery, ISSN 1457-4969, E-ISSN 1799-7267, Vol. 110, no 3, p. 380-385Article in journal (Refereed)
    Abstract [en]

    Background and objective:

    In 2014 we introduced percutaneous internal ring suture as an alternative to open surgery for the treatment of inguinal hernia. This study aims to evaluate the introduction of the procedure at our institution.

    Methods:

    In total, 100 consecutive patients operated with percutaneous internal ring suture were compared with 100 consecutive patients operated with open surgery. The patients were operated from August 2014 until November 2017. Patient demographics, clinical history, operative time, time in theater, and postoperative complications were extracted from charts.

    Results:

    The mean operative time for percutaneous internal ring suture was 26.54 min and for open surgery 39.94 min, P < 0.0001. The total mean operative theater time for percutaneous internal ring suture was 108.95 min and for open surgery 118.4 min, P = 0.0343. During follow-up, two percutaneous internal ring sutures were operated for recurrent hernia. In the open surgery-group, three patients were operated for recurrent hernia, three for secondary testicular retention, and three for metachronous contralateral hernia.

    Conclusions:

    Even when established as a new technique, the percutaneous internal ring suture procedure is safe and results in shorter operative time and shorter theater time compared to open surgery.

  • 14.
    Danielson, Johan
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Pediatric Surgery.
    Svenningsson, Anna
    Department of Pediatric Surgery, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
    Jansson, Patrik
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health.
    Läckgren, Göran
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Pediatric Surgery.
    Controlled long term outcome of pyloromyotomy for pyloric stenosis: No long-term adverse effect2022In: Journal of Pediatric Surgery, ISSN 0022-3468, E-ISSN 1531-5037, Vol. 57, no 11, p. 736-739Article in journal (Refereed)
    Abstract [en]

    Purpose: Pyloromyotomy for pyloric stenosis is one of the more common surgical procedures performed on infants. The long-term effects of the procedure are however unclear. The purpose of this study was to study the effects into adult life, compare them with controls and to see if there is a need for structured follow up of patients.

    Methods: Of the 101 patients operated for pyloric stenosis between 1972 and 1974 at our tertiary referral center 91 could be traced. They were all invited to participate in the study and were sent validated ques-tionnaires (PAGI-SYM, GIQLI) as well as a study-specific questionnaire examining the use of antacid drugs, incidence of gastroscopy and abdominal surgery. Sixty patients responded (66%, mean age 45 years, 46 male) and were included. Thereafter, 600 age and sex-matched controls were sent the same question-naires. 132 responded (22%, 90 male) and were includes as controls.

    Results: No significant differences could be found in any of the examined parameters when looking at the whole material or the male patients. Female patients had higher PAGI-SYM-scores for post prandial fullness (mean 1.11 vs 0.43, P = 0.035) and heartburn (mean 0.59 vs 0.14, P = 0.043) when compared to controls.

    Conclusions: The present study shows that most patients operated for pyloric stenosis during infancy experience no negative effects into adulthood. The finding in the female patient group is interesting but is unlikely to have any clinical implications. The results from this study strongly implicate that there is no need for follow up of patients into adulthood.Level of evidence: Level III.

    Download full text (pdf)
    FULLTEXT01
  • 15.
    Dellenmark-Blom, Michaela
    et al.
    Gothenburg Univ, Queen Silvia Childrens Hosp, Inst Clin Sci, Dept Pediat, S-41685 Gothenburg, Sweden..
    Örnö Ax, Sofie
    Gothenburg Univ, Queen Silvia Childrens Hosp, Inst Clin Sci, Dept Pediat, S-41685 Gothenburg, Sweden.;Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Dept Pediat Surg, Gothenburg, Sweden..
    Öst, Elin
    Karolinska Univ Hosp, Dept Pediat Surg, Stockholm, Sweden.;Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden..
    Svensson, Jan F.
    Karolinska Univ Hosp, Dept Pediat Surg, Stockholm, Sweden.;Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden..
    Kassa, Ann-Marie
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Pediatric Surgery.
    Jönsson, Linus
    Gothenburg Univ, Queen Silvia Childrens Hosp, Inst Clin Sci, Dept Pediat, S-41685 Gothenburg, Sweden.;Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Dept Pediat Surg, Gothenburg, Sweden..
    Abrahamsson, Kate
    Gothenburg Univ, Queen Silvia Childrens Hosp, Inst Clin Sci, Dept Pediat, S-41685 Gothenburg, Sweden.;Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Dept Pediat Surg, Gothenburg, Sweden..
    Gatzinsky, Vladimir
    Gothenburg Univ, Queen Silvia Childrens Hosp, Inst Clin Sci, Dept Pediat, S-41685 Gothenburg, Sweden.;Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Dept Pediat Surg, Gothenburg, Sweden..
    Stenström, Pernilla
    Lund Univ, Skane Univ Hosp, Dept Pediat Surg, Lund, Sweden..
    Tollne, AnnaMaria
    Karolinska Univ Hosp, Dept Pediat Surg, Stockholm, Sweden..
    Omling, Erik
    Lund Univ, Skane Univ Hosp, Dept Pediat Surg, Lund, Sweden..
    Engstrand Lilja, Helene
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Pediatric Surgery.
    Postoperative morbidity and health-related quality of life in children with delayed reconstruction of esophageal atresia: a nationwide Swedish study2022In: Orphanet Journal of Rare Diseases, E-ISSN 1750-1172, Vol. 17, no 1, article id 239Article in journal (Refereed)
    Abstract [en]

    Background

    In 10–15% of children with esophageal atresia (EA) delayed reconstruction of esophageal atresia (DREA) is necessary due to long-gap EA and/or prematurity/low birth weight. They represent a patient subgroup with high risk of complications. We aimed to evaluate postoperative morbidity and health-related quality of life (HRQOL) in a Swedish national cohort of children with DREA.

    Methods

    Postoperative morbidity, age-specific generic HRQOL (PedsQL 4.0) and condition-specific HRQOL (The EA-QOL questionnaires) in children with DREA were compared with children with EA who had primary anastomosis (PA). Factors associated with the DREA group’s HRQOL scores were analyzed using Mann–Whitney U-test and Spearman’s rho. Clinical data was extracted from the medical records. Significance level was p < 0.05.

    Results

    Thirty-four out of 45 families of children with DREA were included and 30 returned the questionnaires(n = 8 children aged 2–7 years; n = 22 children aged 8–18 years). Compared to children with PA(42 children aged 2–7 years; 64 children aged 8–18 years), there were no significant differences in most early postoperative complications. At follow-up, symptom prevalence in children aged 2–7 with DREA ranged from 37.5% (heartburn) to 75% (cough). Further digestive and respiratory symptoms were present in ≥ 50%. In children aged 8–18, it ranged from 14.3% (vomiting) to 40.9% (cough), with other digestive and airway symptoms present in 19.0–27.3%. Except for chest tightness (2–7 years), there were no significant differences in symptom prevalence between children with DREA and PA, nor between their generic or condition-specific HRQOL scores (p > 0.05). More children with DREA underwent esophageal dilatations (both age groups), gastrostomy feeding (2–7 years), and antireflux treatment (8–18 years), p < 0.05. Days to hospital discharge after EA repair and a number of associated anomalies showed a strong negative correlation with HRQOL scores (2–7 years). Presence of cough, airway infection, swallowing difficulties and heartburn were associated with lower HRQOL scores (8–18 years), p < 0.05.

    Conclusions

    Although children with DREA need more treatments, they are not a risk group for postoperative morbidity and impaired HRQOL compared with children with PA. However, those with a long initial hospital stay, several associated anomalies and digestive or respiratory symptoms risk worse HRQOL. This is important information for clinical practice, families and patient stakeholders.

    Download full text (pdf)
    FULLTEXT01
  • 16.
    Delvallée, Clarisse
    et al.
    Laboratoire de Génétique Médicale, Institut de génétique médicale d'Alsace IGMA, INSERM U1112, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg UMRS_1112, Strasbourg, France.
    Nicaise, Samuel
    Laboratoire de Génétique Médicale, Institut de génétique médicale d'Alsace IGMA, INSERM U1112, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg UMRS_1112, Strasbourg, France.
    Antin, Manuela
    Laboratoires de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
    Leuvrey, Anne-Sophie
    Laboratoires de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
    Nourisson, Elsa
    Laboratoires de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
    Leitch, Carmen C
    Advanced Center for Translational and Genetic Medicine (ACT‐GeM), Stanley Manne Children's Research Institute, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
    Kellaris, Georgios
    Advanced Center for Translational and Genetic Medicine (ACT‐GeM), Stanley Manne Children's Research Institute, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
    Stoetzel, Corinne
    Laboratoire de Génétique Médicale, Institut de génétique médicale d'Alsace IGMA, INSERM U1112, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg UMRS_1112, Strasbourg, France.
    Geoffroy, Véronique
    Laboratoire de Génétique Médicale, Institut de génétique médicale d'Alsace IGMA, INSERM U1112, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg UMRS_1112, Strasbourg, France.
    Scheidecker, Sophie
    Laboratoire de Génétique Médicale, Institut de génétique médicale d'Alsace IGMA, INSERM U1112, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg UMRS_1112, Strasbourg, France; Laboratoires de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
    Keren, Boris
    Institut du Cerveau et de la Moelle épinière (ICM), Sorbonne Université, Paris, France; AP‐HP, Hôpital de la Pitié‐Salpêtrière, Département de Génétique, Paris, France.
    Depienne, Christel
    Institut du Cerveau et de la Moelle épinière (ICM), Sorbonne Université, Paris, France; Institute of Human Genetics, University Hospital Essen, University of Duisburg‐Essen, Essen, Germany.
    Klar, Joakim
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Medicinsk genetik och genomik. Uppsala University, Science for Life Laboratory, SciLifeLab. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Dahl, Niklas
    Uppsala University, Science for Life Laboratory, SciLifeLab. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Medicinsk genetik och genomik. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Deleuze, Jean-François
    Centre National de Recherche en Génomique Humaine (CNRGH), Institut de biologie François Jacob, Evry, France.
    Génin, Emmanuelle
    Inserm UMR1078, CHRU Brest, Univ Brest, Brest, France.
    Redon, Richard
    Université de Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
    Demurger, Florence
    Service de Génétique Médicale, Centre Hospitalier Bretagne Atlantique, Vannes, France.
    Devriendt, Koenraad
    Center for Human Genetics, University Hospital Leuven and KU Leuven, Leuven, Belgium.
    Mathieu-Dramard, Michèle
    Centre d'activité de génétique clinique, CLAD nord de France, CHU Amiens, Amiens, France.
    Poitou-Bernert, Christine
    Assistance Publique Hôpitaux de Paris, Nutrition Department Pitié‐Salpêtrière Hospital; Sorbonne Université, INSERM, NutriOmics Research Unit, Paris, France.
    Odent, Sylvie
    Centre de Référence Maladies Rares CLAD‐Ouest, Service de Génétique Clinique, CHU Rennes, Rennes, France ; CNRS, IGDR (Institut de Génétique et Développement de Rennes) UMR 6290, Université de Rennes, Rennes, France.
    Katsanis, Nicholas
    Advanced Center for Translational and Genetic Medicine (ACT‐GeM), Stanley Manne Children's Research Institute, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
    Mandel, Jean-Louis
    Laboratoires de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS UMR 7104, INSERM U964, Université de Strasbourg, Dept Transl Med and Neurogenetics Illkirch, France.
    Davis, Erica E
    Advanced Center for Translational and Genetic Medicine (ACT‐GeM), Stanley Manne Children's Research Institute, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
    Dollfus, Hélène
    Laboratoire de Génétique Médicale, Institut de génétique médicale d'Alsace IGMA, INSERM U1112, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg UMRS_1112, Strasbourg, France ; Service de Génétique Médicale, Hôpitaux Universitaires de Strasbourg, Strasbourg, France ; Filière SENSGENE, Centre de Référence pour les affections rares en génétique ophtalmologique, CARGO, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
    Muller, Jean
    Laboratoire de Génétique Médicale, Institut de génétique médicale d'Alsace IGMA, INSERM U1112, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg UMRS_1112, Strasbourg, France; Laboratoires de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
    A BBS1 SVA F retrotransposon insertion is a frequent cause of Bardet-Biedl syndrome2021In: Clinical Genetics, ISSN 0009-9163, E-ISSN 1399-0004, Vol. 99, no 2, p. 318-324Article in journal (Refereed)
    Abstract [en]

    Bardet-Biedl syndrome (BBS) is a ciliopathy characterized by retinitis pigmentosa, obesity, polydactyly, cognitive impairment and renal failure. Pathogenic variants in 24 genes account for the molecular basis of >80% of cases. Toward saturated discovery of the mutational basis of the disorder, we carefully explored our cohorts and identified a hominid-specific SINE-R/VNTR/Alu type F (SVA-F) insertion in exon 13 of BBS1 in eight families. In six families, the repeat insertion was found in trans with c.1169 T > G, p.Met390Arg and in two families the insertion was found in addition to other recessive BBS loci. Whole genome sequencing, de novo assembly and SNP array analysis were performed to characterize the genomic event. This insertion is extremely rare in the general population (found in 8 alleles of 8 BBS cases but not in >10 800 control individuals from gnomAD-SV) and due to a founder effect. Its 2435 bp sequence contains hallmarks of LINE1 mediated retrotransposition. Functional studies with patient-derived cell lines confirmed that the BBS1 SVA-F is deleterious as evidenced by a significant depletion of both mRNA and protein levels. Such findings highlight the importance of dedicated bioinformatics pipelines to identify all types of variation.

    Download full text (pdf)
    fulltext
  • 17.
    Donoso, Felipe
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Function and morbidity of the esophagus and respiratory system in the growing child with esophageal atresia2020Doctoral thesis, comprehensive summary (Other academic)
    Abstract [en]

    Background: Esophageal atresia (EA) is a congenital malformation that consists of various degrees of discontinuity of the esophagus and affects about 1:3000 live births. EA is usually corrected at birth with survival rates over 90%, which has shifted the focus towards improvement of associated morbidity and health-related quality of life.

    The aims of this thesis were to investigate how morbidity in the esophagus and respiratory system in children with EA relates with diagnostic and function tests included in the follow-up programme after EA repair and evaluate the efficacy of the recommended proton pump inhibitor (PPI) prophylaxis.

    Methods: The study population consists of 169 children treated for EA in the Department of Pediatric Surgery at University Children’s Hospital, Uppsala between 1994 and 2018. The patients participated in the multidisciplinary follow-up programme that was established in 2011 for patients with EA. The thesis is based on four observational studies that investigated the outcome of the patients and generalisability of the results; risk factors for anastomotic strictures and the efficacy of PPI-treatment regimen in reducing its incidence; pulmonary function and risk factors for pulmonary function impairment; and association between ambulatory 24h pH test, endoscopic findings of esophagitis and hiatal hernia, symptoms of gastroesophageal reflux (GER), and histopathological esophagitis. The studies were approved by the Regional Committee for Medical Research Ethics.

    Results: The demographics and outcome of our study population are comparable with centres of higher caseload, showing low mortality rate but significant morbidity, especially considering anastomotic strictures and patients with long gap EA. Long gap EA, higher birth weight, and anastomotic tension were independent risk factors of anastomotic stricture formation. Prophylactic PPI-treatment did not reduce anastomotic strictures compared with symptomatic PPI-treatment. Respiratory morbidity and obstruction of the airways were common in children and adolescents after EA repair. The risk for pulmonary function impairment increased with lower birth weight and older age at follow-up. Neither ambulatory 24h pH-metry, clinical symptoms of GER nor endoscopic esophagitis were reliable tools to identify histopathological esophagitis in children and adolescents after EA repair and cannot replace esophageal biopsies.

    Conclusion: The poor correlation between clinical symptoms and morbidity of the esophagus and respiratory system justifies the need of clinical follow-up programmes in patients with EA. A general recommendation to stop prophylactic PPI-treatment after EA repair cannot be supported, however, sufficient evidence is available to support randomised controlled studies.

    List of papers
    1. Outcome and management in infants with esophageal atresia: a single centre observational study
    Open this publication in new window or tab >>Outcome and management in infants with esophageal atresia: a single centre observational study
    Show others...
    2016 (English)In: Journal of Pediatric Surgery, ISSN 0022-3468, E-ISSN 1531-5037, Vol. 51, no 9, p. 1421-1425Article in journal (Refereed) Published
    Abstract [en]

    Background/Purpose: A successful outcome in the repair of esophageal atresia (EA) is associated with a high quality pediatric surgical centre, however there are several controversies regarding the optimal management. The aim of this study was to investigate the outcome and management EA in a single pediatric surgical centre.

    Methods: Medical records of infants with repaired EA from 1994 to 2013 were reviewed.

    Results: 129 infants were included. Median follow-up was 5.3 (range 0.1-21) years. Overall survival was 94.6%, incidences of anastomotic leakage 7.0%, recurrent fistula 4.6% and anastomotic stricture 53.5% (36.2% within first year). In long gap EA (n = 13), delayed primary anastomosis was performed in 9 (69.2%), gastric tube in 3 (23.1%) and gastric transposition in one (7.7%) infants. The incidences of anastomotic leakage and stricture in long gap EA were, 23.1% and 69.2%, respectively. Peroperative tracheobronchoscopy and postoperative esophagography were implemented as a routine during the study-period, but chest drains were routinely abandoned.

    Conclusion: The outcome in this study is fully comparable with recent international reports showing a low mortality but a significant morbidity, especially considering anastomotic strictures and LGEA. Multicenter EA registry with long-term follow up may help to establish best management of EA.

    National Category
    Surgery
    Identifiers
    urn:nbn:se:uu:diva-304712 (URN)10.1016/j.jpedsurg.2016.03.010 (DOI)000382243300005 ()27114309 (PubMedID)
    Available from: 2016-10-07 Created: 2016-10-07 Last updated: 2020-10-19Bibliographically approved
    2. Risk Factors for Anastomotic Strictures after Esophageal Atresia Repair: Prophylactic Proton Pump Inhibitors Do Not Reduce the Incidence of Strictures
    Open this publication in new window or tab >>Risk Factors for Anastomotic Strictures after Esophageal Atresia Repair: Prophylactic Proton Pump Inhibitors Do Not Reduce the Incidence of Strictures
    2017 (English)In: European journal of pediatric surgery, ISSN 0939-7248, E-ISSN 1439-359X, Vol. 27, no 1, p. 50-55Article in journal (Refereed) Published
    Abstract [en]

    Background: Since 2005, infants with esophageal atresia (EA) in our unit are given prophylactic proton pump inhibitors (PPI) after repair until 1 year of age. The aims of this study were to identify risk factors for anastomotic strictures (AS) and to assess the efficacy of postoperative PPI prophylaxis in reducing the incidence of AS compared with symptomatic PPI. Methods Patients who underwent EA repair from 1994 to 2013 in our unit were included in this retrospective observational study approved by the local ethics review board. They were divided into two subgroups; symptomatic PPI-group with EA repair from 1994 to 2004 and prophylactic PPI-group with EA repair from 2005 to 2013. Data were collected from the patient records. Potential risk factors for AS analyzed were gender, long gap EA, birth weight, premature birth (< 37 gestational weeks), anastomotic tension, and anastomotic leakage. Number of dilatations until the age of 1 and 5 years were recorded. To evaluate risk factors for AS and the effect of prophylactic PPI Logistic, Cox and Poisson regression models were used. For descriptive statistics Fisher exact test and Wilcoxon rank sum test were used. Results A total of 128 patients were included. Patient characteristics, surgical method, grading of anastomotic tension, complications, and survival rates did not differ significantly between the symptomatic PPI-group (n = 71) and the prophylactic PPI-group (n = 57). Comparing the symptomatic and prophylactic PPI-group, there was no significant difference in the median age at the first AS (9.3 vs 6 mo), the number of dilatations until 1 year (2 vs 2) and 5 years (5 vs 4), or the incidence of anastomotic stricture (56.5% vs 50.9%). Long gap EA, high birth weight, and anastomotic tension were found to be independent risk factors. Conclusion Surgeons should aim to perform anastomosis under less tension at EA repair. Prophylactic PPI-treatment does not appear to reduce the rate of AS. Randomized controlled trials with larger study populations are needed to further evaluate the efficacy of prophylactic PPI.

    Place, publisher, year, edition, pages
    GEORG THIEME VERLAG KG, 2017
    Keywords
    esophageal atresia, PPI, proton pump inhibitor, risk factor, stricture
    National Category
    Surgery Pediatrics
    Identifiers
    urn:nbn:se:uu:diva-320712 (URN)10.1055/s-0036-1593607 (DOI)000394882700012 ()27769086 (PubMedID)
    Available from: 2017-04-24 Created: 2017-04-24 Last updated: 2020-10-19Bibliographically approved
    3. Pulmonary function in children and adolescents after esophageal atresia repair
    Open this publication in new window or tab >>Pulmonary function in children and adolescents after esophageal atresia repair
    2020 (English)In: Pediatric Pulmonology, ISSN 8755-6863, E-ISSN 1099-0496, Vol. 55, no 1, p. 206-213Article in journal (Refereed) Published
    Abstract [en]

    Introduction

    Respiratory morbidity after esophageal atresia (EA) is common. The aims of this study were to assess pulmonary function, to identify risk factors for pulmonary function impairment (PFI), and to investigate the relations between respiratory morbidity, defined as medical treatment for respiratory symptoms or recent pneumonia and PFI after EA repair.

    Material and Methods

    Single center retrospective observational study including patients with EA who participated in the follow‐up program for 8‐ or 15‐year old patients from 2014 to 2018 and performed pulmonary function testing by body plethysmography, dynamic spirometry, impulse oscillometry, and diffusing capacity of the lungs. Univariate and multiple stepwise logistic regression with PFI as outcome were performed. Anastomotic leak, episodes of general anesthesia, extubation day, birth weight, age at follow up, gross classification, and abnormal reflux index were independent variables.

    Results

    In total, 47 patients were included. PFI was found in 19 patients (41%) and 16 out of 19 patients (84%) had an obstructive pattern. Respiratory morbidity was found in 23 (52%, NA = 3) of the patients with no correlation to PFI. Birth weight, age at follow‐up, and episodes of general anesthesia were identified as risk factors for PFI.

    Conclusion

    Respiratory morbidity and PFI were common in children and adolescents after EA repair. The major component of PFI was obstruction of the airways. The risk for PFI increased with lower birth weight and older age at follow up. The poor correlation between respiratory morbidity and PFI motivates the need of clinical follow up including pulmonary function tests.

    National Category
    Respiratory Medicine and Allergy Surgery
    Research subject
    Pediatric Surgery
    Identifiers
    urn:nbn:se:uu:diva-405373 (URN)10.1002/ppul.24517 (DOI)000486950100001 ()31535483 (PubMedID)
    Available from: 2020-02-27 Created: 2020-02-27 Last updated: 2021-03-25Bibliographically approved
    4. Evaluation of predictors for histopathological esophagitis in young children and adolescents with esophageal atresia.
    Open this publication in new window or tab >>Evaluation of predictors for histopathological esophagitis in young children and adolescents with esophageal atresia.
    (English)Manuscript (preprint) (Other academic)
    National Category
    Medical and Health Sciences
    Research subject
    Medical Science
    Identifiers
    urn:nbn:se:uu:diva-422953 (URN)
    Available from: 2020-10-19 Created: 2020-10-19 Last updated: 2020-10-19
    Download full text (pdf)
    fulltext
    Download (jpg)
    presentationsbild
  • 18.
    Donoso, Felipe
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Beckman, Anna
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.
    Malinovschi, Andrei
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology, Integrative Physiology. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical Physiology. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Lung- allergy- and sleep research.
    Engstrand Lilja, Helene
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Evaluation of predictors for histopathological esophagitis in young children and adolescents with esophageal atresia.Manuscript (preprint) (Other academic)
  • 19.
    Donoso, Felipe
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Pediatric Surgery.
    Beckman, Anna
    Malinovschi, Andrei
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology, Integrative Physiology. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical Physiology. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Lung- allergy- and sleep research.
    Engstrand Lilja, Helene
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Pediatric Surgery.
    Predictors of histopathological esophagitis in infants and adolescents with esophageal atresia within a national follow-up programme.2022In: PLOS ONE, E-ISSN 1932-6203, Vol. 17, no 4, article id e0266995Article in journal (Refereed)
    Abstract [en]

    PURPOSE: Esophageal atresia (EA) is a congenital anomaly of the foregut. Although the survival has improved over the years there is a significant gastrointestinal morbidity affecting physical function and health-related quality of life. The aims of the study were to identify and evaluate predictors of histopathological esophagitis in infants and adolescents with EA.

    METHODS: Single centre, cross-sectional study including one and 15-year-old patients operated for EA that participated in the national follow-up programme between 2012 and 2020 according to a pre-established protocol including upper endoscopy with oesophageal biopsies and 24h-pH-test. Data was collected from patients' medical records and pH-analysis software. Regression models were used to identify predictors of histopathological oesophagitis. Possible predictors were abnormal reflux index, endoscopic esophagitis, hiatal hernia, symptoms of gastroesophageal reflux (GER) and age.

    RESULTS: 65 patients were included, 47 children and 18 adolescents. All children were treated with PPI during their first year of life. Symptoms of GER were reported by 13 (31.7%) of the infant's caregivers, 34 of the children (72.3%) had abnormal reflux index and 32 (68.1%) had histopathological esophagitis. The corresponding numbers for adolescents were 8 (50%), 15 (83.3%) and 10 (55.6%). We found no significant associations between histopathological esophagitis and endoscopic esophagitis, symptoms of GER, hiatus hernia or age group. Abnormal reflux index was an independent predictor of histopathological esophagitis. Seven patients with normal reflux index had histopathological esophagitis, all grade I.

    CONCLUSIONS: We found a high prevalence of histopathological esophagitis despite PPI treatment in accordance with recommendations. No significant difference between the two age groups was seen. Abnormal reflux index was an independent predictor of histopathological esophagitis. However, we cannot recommend the use of pH-metry as a substitute for esophageal biopsies; future studies are needed to elucidate if esophageal biopsies might be postponed in infants with normal reflux index.

    Download full text (pdf)
    fulltext
  • 20.
    Donoso, Felipe
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery. Department of Pediatric Surgery, Uppsala University Children's Hospital, Uppsala, Sweden.
    Hedenström, Hans
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical Physiology.
    Malinovschi, Andrei
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical Physiology.
    Engstrand Lilja, Helene
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery. Department of Pediatric Surgery, Uppsala University Children's Hospital, Uppsala, Sweden.
    Pulmonary function in children and adolescents after esophageal atresia repair2020In: Pediatric Pulmonology, ISSN 8755-6863, E-ISSN 1099-0496, Vol. 55, no 1, p. 206-213Article in journal (Refereed)
    Abstract [en]

    Introduction

    Respiratory morbidity after esophageal atresia (EA) is common. The aims of this study were to assess pulmonary function, to identify risk factors for pulmonary function impairment (PFI), and to investigate the relations between respiratory morbidity, defined as medical treatment for respiratory symptoms or recent pneumonia and PFI after EA repair.

    Material and Methods

    Single center retrospective observational study including patients with EA who participated in the follow‐up program for 8‐ or 15‐year old patients from 2014 to 2018 and performed pulmonary function testing by body plethysmography, dynamic spirometry, impulse oscillometry, and diffusing capacity of the lungs. Univariate and multiple stepwise logistic regression with PFI as outcome were performed. Anastomotic leak, episodes of general anesthesia, extubation day, birth weight, age at follow up, gross classification, and abnormal reflux index were independent variables.

    Results

    In total, 47 patients were included. PFI was found in 19 patients (41%) and 16 out of 19 patients (84%) had an obstructive pattern. Respiratory morbidity was found in 23 (52%, NA = 3) of the patients with no correlation to PFI. Birth weight, age at follow‐up, and episodes of general anesthesia were identified as risk factors for PFI.

    Conclusion

    Respiratory morbidity and PFI were common in children and adolescents after EA repair. The major component of PFI was obstruction of the airways. The risk for PFI increased with lower birth weight and older age at follow up. The poor correlation between respiratory morbidity and PFI motivates the need of clinical follow up including pulmonary function tests.

    Download full text (pdf)
    fulltext
  • 21.
    Ebrahimi-Fakhari, Darius
    et al.
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA..
    Teinert, Julian
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.;Univ Hosp Heidelberg, Ctr Paediat & Adolescent Med, Div Child Neurol & Metab Med, Heidelberg, Germany..
    Behne, Robert
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.;Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany..
    Wimmer, Miriam
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA..
    D'Amore, Angelica
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.;IRCCS Fdn Stella Maris, Mol Med, Pisa, Italy..
    Eberhardt, Kathrin
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA..
    Brechmann, Barbara
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA..
    Ziegler, Marvin
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA..
    Jensen, Dana M.
    Univ Washington, Dept Pediat, Div Genet Med, Seattle, WA 98195 USA..
    Nagabhyrava, Premsai
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.;Harvard Med Sch, Translat Neurosci Ctr, Boston Childrens Hosp, Boston, MA 02115 USA..
    Geisel, Gregory
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.;Harvard Med Sch, Translat Neurosci Ctr, Boston Childrens Hosp, Boston, MA 02115 USA..
    Carmody, Erin
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.;Harvard Med Sch, Translat Neurosci Ctr, Boston Childrens Hosp, Boston, MA 02115 USA..
    Shamshad, Uzma
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.;Harvard Med Sch, Translat Neurosci Ctr, Boston Childrens Hosp, Boston, MA 02115 USA..
    Dies, Kira A.
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.;Harvard Med Sch, Translat Neurosci Ctr, Boston Childrens Hosp, Boston, MA 02115 USA..
    Yuskaitis, Christopher J.
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA..
    Salussolia, Catherine L.
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA..
    Ebrahimi-Fakhari, Daniel
    Saarland Univ, Med Ctr, Pediat Neurol, Homburg, Germany.;Univ Childrens Hosp Muenster, Dept Gen Pediat, Munster, Germany..
    Pearson, Toni S.
    Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA..
    Saffari, Afshin
    Univ Hosp Heidelberg, Ctr Paediat & Adolescent Med, Div Child Neurol & Metab Med, Heidelberg, Germany..
    Ziegler, Andreas
    Univ Hosp Heidelberg, Ctr Paediat & Adolescent Med, Div Child Neurol & Metab Med, Heidelberg, Germany..
    Koelker, Stefan
    Univ Hosp Heidelberg, Ctr Paediat & Adolescent Med, Div Child Neurol & Metab Med, Heidelberg, Germany..
    Volkmann, Jens
    Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany..
    Wiesener, Antje
    Friedrich Alexander Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany..
    Bearden, David R.
    Univ Rochester, Sch Med, Child Neurol, Rochester, NY USA..
    Lakhani, Shenela
    Weill Cornell Med Coll, Ctr Neurogenet, New York, NY USA..
    Segal, Devorah
    Weill Cornell Med Coll, Ctr Neurogenet, New York, NY USA.;Weill Cornell Med, Div Child Neurol, New York, NY USA..
    Udwadia-Hegde, Anaita
    Jaslok Hosp & Res Ctr, Dept Pediat Neurol, Mumbai, Maharashtra, India..
    Martinuzzi, Andrea
    IRCCS E Medea, Unita Operat Conegliano, Sci Inst, Treviso, Italy..
    Hirst, Jennifer
    Univ Cambridge, Cambridge Inst Med Res, Cambridge, England..
    Perlman, Seth
    Univ Iowa, Dept Pediat, Carver Coll Med, Div Neurol, Iowa City, IA 52242 USA..
    Takiyama, Yoshihisa
    Univ Yamanashi, Dept Neurol, Kofu, Yamanashi, Japan..
    Xiromerisiou, Georgia
    Papageorgiou Hosp, Dept Neurol, Thessaloniki, Greece..
    Vill, Katharina
    Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Pediat Neurol & Dev Med, Munich, Germany..
    Walker, William O.
    Univ Washington, Sch Med, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98195 USA..
    Shukla, Anju
    Manipal Acad Higher Educ, Kasturba Med Coll, Dept Med Genet, Manipal, Karnataka, India..
    Gupta, Rachana Dubey
    Medanta Hosp, Pediat Neurol, Indore, Madhya Pradesh, India..
    Dahl, Niklas
    Uppsala University, Science for Life Laboratory, SciLifeLab. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Medicinsk genetik och genomik. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Aksoy, Ayse
    Dr Sami Ulus Hosp, Pediat Neurol, Ankara, Turkey..
    Verhelst, Helene
    Ghent Univ Hosp, Pediat Neurol, Ghent, Belgium..
    Delgado, Mauricio R.
    Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX USA..
    Pourova, Radka Kremlikova
    Charles Univ Prague, Med Fac 2, Dept Biol & Med Genet, Prague, Czech Republic.;UH Motol, Prague, Czech Republic..
    Sadek, Abdelrahim A.
    Sohag Univ, Fac Med, Pediat Neurol, Sohag, Egypt..
    Elkhateeb, Nour M.
    Cairo Univ, Pediat Neurol, Cairo, Egypt..
    Blumkin, Lubov
    Tel Aviv Univ, Wolfson Med Ctr, Sackler Sch Med, Pediat Neurol Unit,Movement Disorders Clin, Tel Aviv, Israel..
    Brea-Fernandez, Alejandro J.
    CIBERER, Grp Med Xenom, Santiago De Compostela, Spain..
    Dacruz-Alvarez, David
    Complexo Hosp Univ, Neurol Pediat, Santiago De Compostela, Spain..
    Smol, Thomas
    CHU Lille, RADEME, Inst Genet Med, Lille, France..
    Ghoumid, Jamal
    CHU Lille, RADEME, Inst Genet Med, Lille, France..
    Miguel, Diego
    Univ Fed Bahia, Serv Genet Med, Salvador, BA, Brazil..
    Heine, Constanze
    Univ Hosp Leipzig, Inst Human Genet, Leipzig, Germany..
    Schlump, Jan-Ulrich
    Evangel Krankenhaus, Pediat, Oberhausen, Germany..
    Langen, Hendrik
    Sozialpadiatr Zentrum Hannover, Hannover, Germany..
    Baets, Jonathan
    Univ Antwerp, Neurogenet Grp, Antwerp, Belgium.;Univ Antwerp, Neuromuscular Reference Ctr, Antwerp, Belgium.;Antwerp Univ Hosp, Antwerp, Belgium..
    Bulk, Saskia
    Ctr Hosp Univ Liege, Med Genet, Liege, Belgium..
    Darvish, Hossein
    Semnan Univ Med Sci, Canc Res Ctr, Semnan, Iran.;Semnan Univ Med Sci, Dept Med Genet, Semnan, Iran..
    Bakhtiari, Somayeh
    Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA..
    Kruer, Michael C.
    Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA..
    Lim-Melia, Elizabeth
    Maria Fareri Childrens Hosp, Pediat Med Genet, Valhalla, NY USA..
    Aydinli, Nur
    Acibadem Mehmet Ali Aydinlar Univ, Dept Pediat, Pediat Genet, Istanbul, Turkey..
    Alanay, Yasemin
    Istanbul Med Fac, Pediat Neurol, Istanbul, Turkey..
    El-Rashidy, Omnia
    Ain Shams Univ, Pediat, Cairo, Egypt..
    Nampoothiri, Sheela
    Amrita Inst Med Sci & Res Ctr, Cochin, Kerala, India..
    Patel, Chirag
    Royal Brisbane & Womens Hosp, Genet Hlth Queensland, Brisbane, Qld, Australia..
    Beetz, Christian
    Centogene AG, Rostock, Germany..
    Bauer, Peter
    Centogene AG, Rostock, Germany..
    Yoon, Grace
    Univ Toronto, Hosp Sick Children, Dept Paediat, Div Clin & Metab Genet, Toronto, ON, Canada..
    Guillot, Mireille
    Hosp Sick Children, Dept Paediat, Toronto, ON, Canada.;Univ Toronto, Toronto, ON, Canada..
    Miller, Steven P.
    Hosp Sick Children, Dept Paediat, Toronto, ON, Canada.;Univ Toronto, Toronto, ON, Canada..
    Bourinaris, Thomas
    UCL Inst Neurol, Dept Mol Neurosci, London, England..
    Houlden, Henry
    UCL Inst Neurol, Dept Mol Neurosci, London, England..
    Robelin, Laura
    Hop Univ Strasbourg, Serv Neurol, Strasbourg, France..
    Anheim, Mathieu
    Hop Univ Strasbourg, Serv Neurol, Strasbourg, France..
    Alamri, Abdullah S.
    Natl Neurosci Inst, King Fahad Med City, Pediat Neurol, Riyadh, Saudi Arabia..
    Mahmoud, Adel A. H.
    Imam Abdulrahman Bin Faisal Univ, Pediat, Dammam, Saudi Arabia..
    Inaloo, Soroor
    Shiraz Univ Med Sci, Neonatal Res Ctr, Shiraz, Iran..
    Habibzadeh, Parham
    Shiraz Univ Med Sci, Persian BayanGene Res & Training Ctr, Shiraz, Iran..
    Faghihi, Mohammad Ali
    Shiraz Univ Med Sci, Persian BayanGene Res & Training Ctr, Shiraz, Iran.;Univ Miami, Ctr Therapeut Innovat, Miami, FL USA.;Univ Miami, Dept Psychiat & Behav Sci, Miami, FL USA..
    Jansen, Anna C.
    UZ Brussel, Pediat Neurol Unit, Dept Pediat, Brussels, Belgium..
    Brock, Stefanie
    UZ Brussel, Pediat Neurol Unit, Dept Pediat, Brussels, Belgium..
    Roubertie, Agathe
    CHU Montpellier, Pediat Neurol, Montpellier, France..
    Darras, Basil T.
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA..
    Agrawal, Pankaj B.
    Harvard Med Sch, Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Newborn Med, Boston, MA 02115 USA.;Harvard Med Sch, Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA 02115 USA..
    Santorelli, Filippo M.
    IRCCS Fdn Stella Maris, Mol Med, Pisa, Italy..
    Gleeson, Joseph
    Rady Childrens Hosp, Rady Childrens Inst Genom Med, San Diego, CA USA..
    Zaki, Maha S.
    Natl Res Ctr, Clin Genet Human Genet & Genome Res Div, Cairo, Egypt..
    Sheikh, Sarah, I
    Celgene, Translat Neurosci, Cambridge, MA USA..
    Bennett, James T.
    Univ Washington, Dept Pediat, Div Genet Med, Seattle, WA 98195 USA..
    Sahin, Mustafa
    Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.;Harvard Med Sch, Translat Neurosci Ctr, Boston Childrens Hosp, Boston, MA 02115 USA..
    Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia2020In: Brain, ISSN 0006-8950, E-ISSN 1460-2156, Vol. 143, no 10, p. 2929-2944Article in journal (Refereed)
    Abstract [en]

    Bi-allelic loss-of-function variants in genes that encode subunits of the adaptor protein complex 4 (AP-4) lead to prototypical yet poorly understood forms of childhood-onset and complex hereditary spastic paraplegia: SPG47 (AP4B1), SPG50 (AP4M1), SPG51 (AP4E1) and SPG52 (AP4S1). Here, we report a detailed cross-sectional analysis of clinical, imaging and molecular data of 156 patients from 101 families. Enrolled patients were of diverse ethnic backgrounds and covered a wide age range (1.0-49.3 years). While the mean age at symptom onset was 0.8 +/- 0.6 years [standard deviation (SD), range 0.2-5.0], the mean age at diagnosis was 10.2 +/- 8.5 years (SD, range 0.1-46.3). We define a set of core features: early-onset developmental delay with delayed motor milestones and significant speech delay (50% non-verbal); intellectual disability in the moderate to severe range; mild hypotonia in infancy followed by spastic diplegia (mean age: 8.4 +/- 5.1 years, SD) and later tetraplegia (mean age: 16.1 +/- 9.8 years, SD); postnatal microcephaly (83%); foot deformities (69%); and epilepsy (66%) that is intractable in a subset. At last follow-up, 36% ambulated with assistance (mean age: 8.9 +/- 6.4 years, SD) and 54% were wheelchair-dependent (mean age: 13.4 +/- 9.8 years, SD). Episodes of stereotypic laughing, possibly consistent with a pseudobulbar affect, were found in 56% of patients. Key features on neuroimaging include a thin corpus callosum (90%), ventriculomegaly (65%) often with colpocephaly, and periventricular white-matter signal abnormalities (68%). Iron deposition and polymicrogyria were found in a subset of patients. AP4B1-associated SPG47 and AP4M1-associated SPG50 accounted for the majority of cases. About two-thirds of patients were born to consanguineous parents, and 82% carried homozygous variants. Over 70 unique variants were present, the majority of which are frameshift or nonsense mutations. To track disease progression across the age spectrum, we defined the relationship between disease severity as measured by several rating scales and disease duration. We found that the presence of epilepsy, which manifested before the age of 3 years in the majority of patients, was associated with worse motor outcomes. Exploring genotype-phenotype correlations, we found that disease severity and major phenotypes were equally distributed among the four subtypes, establishing that SPG47, SPG50, SPG51 and SPG52 share a common phenotype, an 'AP-4 deficiency syndrome'. By delineating the core clinical, imaging, and molecular features of AP-4-associated hereditary spastic paraplegia across the age spectrum our results will facilitate early diagnosis, enable counselling and anticipatory guidance of affected families and help define endpoints for future interventional trials.

  • 22.
    Edner, Ann
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Lindström Nilsson, Maria
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Melhus, Åsa
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical Microbiology.
    Low risk of transmission of pathogenic bacteria between children and the assistance dog during animal-assisted if strict rules are followed2021In: Journal of Hospital Infection, ISSN 0195-6701, E-ISSN 1532-2939, Vol. 115, p. 5-9Article in journal (Refereed)
    Abstract [en]

    This study explored the bacterial transmission between patients and dogs during dog assisted therapy (DAT). Twenty children (55% girls) with a median age of 7 years (range 3-17 years) were included. Two dogs assisted and the conditions were more restricted hygienically with dog 2. Samples from child and dog were collected and cultured before and after each DAT visit. The results showed that dog 1 transmitted bacteria repeatedly to the children. No bacteria were transmitted with dog 2. In conclusion, exchange of bacteria can occur between dog and child during DAT, but it can be reduced by simple infection control measures. (c) 2021 Published by Elsevier Ltd on behalf of The Healthcare Infection Society.

  • 23.
    Fredriksson, Fanny
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Engstrand Lilja, Helene
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Survival rates for surgically treated necrotising enterocolitis have improved over the last four decades2019In: Acta Paediatrica, ISSN 0803-5253, E-ISSN 1651-2227, Vol. 108, no 9, p. 1603-1608Article in journal (Refereed)
    Abstract [en]

    Aim Improved survival rates for premature infants have also increased the population at risk of necrotising enterocolitis (NEC). This study evaluated the outcomes of surgically treated NEC and identified risk factors for mortality, intestinal failure (IF) and IF associated liver disease (IFALD). Methods This was a retrospective observational study of 131 infants with surgically treated NEC from 1976 to 2016 in a Swedish tertiary referral centre: 20 in 1976-1996, 33 in 1997-2006 and 78 in 2007-2016. Data were extracted from medical records, and the Cox regression model was used to identify risk factors. Results When the first and last periods were compared, they showed decreases in both gestational age, from 30 to 26 weeks, and mortality rates, from 45% to 29%. IF was found in 67 patients (56%), IFALD in 41 patients (34%) and short bowel syndrome (SBS) in 13 (19%). The incidence of IF was high, even in infants without SBS. Low gestational age was an independent risk factor for mortality. No risk factors were identified for IF or IFALD. Conclusion Survival rates for NEC improved from 1976-2016, despite a decrease in gestational age. Clinicians should be particularly aware of the risk of infants without SBS developing IF.

    Download full text (pdf)
    fulltext
  • 24.
    Fredriksson, Fanny
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Pediatric Surgery. Section of Pediatric Surgery, Uppsala University Children's Hospital, Uppsala, Sweden.
    Nyström, Niklas
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Paediatric Inflammation, Metabolism and Child Health Research. Section of Pediatric Gastroenterology, Uppsala University Children's Hospital, Uppsala, Sweden.
    Waldenvik, Kajsa
    Section of Pediatric Gastroenterology, Uppsala University Children's Hospital, Uppsala, Sweden.
    Ördén, Helene
    Section of Pediatric Gastroenterology, Uppsala University Children's Hospital, Uppsala, Sweden.
    Lindblom, Maja
    Section of Pediatric Surgery, Uppsala University Children's Hospital, Uppsala, Sweden.
    Paulsson, Mattias
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Neuropediatrics/Paediatric oncology. Hospital Pharmacy, Uppsala University Children's Hospital, Uppsala, Sweden.
    Finkel, Yigael
    Section of Pediatric Gastroenterology, Uppsala University Children's Hospital, Uppsala, Sweden.
    Engstrand Lilja, Helene
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Pediatric Surgery. Section of Pediatric Surgery, Uppsala University Children's Hospital, Uppsala, Sweden.
    Improved Outcome of Intestinal Failure in Preterm Infants2020In: Journal of Pediatric Gastroenterology and Nutrition - JPGN, ISSN 0277-2116, E-ISSN 1536-4801, Vol. 71, no 2, p. 223-231Article in journal (Refereed)
    Abstract [en]

    OBJECTIVE: The aims were to evaluate the outcome and to identify predictors for survival and enteral autonomy in neonatal intestinal failure (IF).

    METHODS: A retrospective observational study in a Swedish tertiary centre of children born between 1995 and 2016 with neonatal IF, defined as dependency on parenteral nutrition (PN) ≥60 days, starting with PN before the age of 44 gestational weeks. Data were extracted from medical records and predictors for survival and enteral autonomy were identified by the Cox regression model. Time to death and weaning off PN analysis were performed with Kaplan-Meier curves including log rank test.

    RESULTS: In total, 105 children were included. Median gestational age was 28 weeks (22-42), 50% were born extremely preterm (<28 gestational weeks). PN started at a median age of two days (0-147) with a median duration of 196 days (60-3091). Necrotising enterocolitis was the dominating cause of IF (61%). Overall survival was 88%, five children died of sepsis and four of intestinal failure-associated liver disease. Survival increased from 75% during 1995-2008 to 96% during 2009-2016 (p = 0.0040). Age-adjusted small bowel length of >50% and birth 2009-2016 were predictors for survival. Enteral autonomy was achieved in 87%, with positive prediction by small bowel length of >25% of expected for gestational age and remaining ileocaecal valve.

    CONCLUSION: Preterm neonates with IF, at high risk of IF associated morbidity, showed a high overall survival rate. Small-bowel length and being born 2009-2016 were predictors for survival and remaining ICV and small-bowel length were predictors for enteral autonomy.

    Download full text (pdf)
    fulltext
  • 25.
    Fredriksson, Fanny
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Sellberg, Felix
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Clinical Immunology.
    Bowden, Tim
    Uppsala University, Disciplinary Domain of Science and Technology, Chemistry, Department of Chemistry - Ångström, Polymer Chemistry.
    Engstrand, T.
    Karolinska Univ Hosp, Dept Reconstruct Plast Surg, SE-17176 Stockholm, Sweden.;Karolinska Inst, SE-17176 Stockholm, Sweden..
    Berglund, David
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Clinical Immunology.
    Engstrand Lilja, Helene
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Sutures impregnated with carbazate-activated polyvinyl alcohol reduce intraperitoneal adhesions2017In: Journal of Pediatric Surgery, ISSN 0022-3468, E-ISSN 1531-5037, Vol. 52, no 11, p. 1853-1858Article in journal (Refereed)
    Abstract [en]

    Background: Intraperitoneal adhesions cause significant morbidity. They occur after peritoneal trauma, which induces oxidative stress with production of inflammatory cytokines, peroxidized proteins (carbonyls) and lipids (aldehydes). This study aimed to investigate if carbazate-activated polyvinyl alcohol (PVAC), an aldehyde-carbonyl inhibitor, can reduce intraperitoneal adhesions in an experimental model.

    Material and methods: Male Sprague-Dawley rats (n = 110) underwent laparotomy, cecal abrasion and construction of a small bowel anastomosis. They either were treated with intraperitoneal instillation of PVAC or were sutured with PVAC-impregnated sutures. Thromboelastography analysis was performed using human blood and PVAC. The lipid peroxidation product malondialdehyde (MDA) and inflammatory cytokines IL-1 beta and IL-6 were quantified in peritoneal fluid. At day 7, bursting pressure of the anastomosis was measured and adhesions were blindly scored.

    Results: PVAC in human blood decreased the production of the fibrin-thrombocyte mesh without affecting the coagulation cascade. MDA, IL-1 beta and IL-6 were increased after 6 h without significant difference between the groups. PVAC-impregnated sutures reduced intraperitoneal adhesions compared to controls (p = 0.0406) while intraperitoneal instillation of PVAC had no effect. Anastomotic bursting pressure was unchanged.

    Conclusions: Intervention with an aldehyde-carbonyl inhibitor locally in the wound by PVAC-impregnated sutures might be a new strategy to reduce intraperitoneal adhesions.

  • 26.
    Gehlen, Jan
    et al.
    Univ Hosp Marburg, Inst Human Genet, Marburg, Germany..
    Giel, Ann-Sophie
    Univ Hosp Marburg, Inst Human Genet, Marburg, Germany..
    Koellges, Ricarda
    Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany.;Univ Hosp Bonn, Bonn, Germany.;Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany..
    Haas, Stephan L.
    Karolinska Univ Hosp, Dept Upper GI Dis, Stockholm, Sweden.;Karolinska Inst, Unit Gastroenterol & Rheumatol, Stockholm, Sweden..
    Zhang, Rong
    Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany.;Univ Hosp Bonn, Bonn, Germany.;Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany..
    Trcka, Jiri
    Charles Univ Prague, Dept Paediat Surg, Fac Med 2, Prague, Czech Republic.;Motol Univ Hosp, Prague, Czech Republic..
    Sungur, Ayse O.
    Univ Marburg, Behav Neurosci Expt & Biol Psychol, Marburg, Germany..
    Renziehausen, Florian
    Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany.;Univ Hosp Bonn, Bonn, Germany.;Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany..
    Bornholdt, Dorothea
    Univ Hosp Marburg, Inst Human Genet, Marburg, Germany..
    Jung, Daphne
    Univ Hosp Marburg, Inst Human Genet, Marburg, Germany.;Univ Childrens Hosp, Dept Pediat Surg, Marburg, Germany..
    Hoyer, Paul D.
    Univ Childrens Hosp, Dept Pediat Surg, Marburg, Germany..
    Nordenskjold, Agneta
    Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.;Karolinska Univ Hosp, Dept Paediat Surg, Stockholm, Sweden..
    Tibboel, Dick
    Sophia Childrens Univ Hosp, Dept Pediat Surg & Intens Care, Erasmus Med Ctr, Rotterdam, Netherlands..
    Vlot, John
    Sophia Childrens Univ Hosp, Dept Pediat Surg & Intens Care, Erasmus Med Ctr, Rotterdam, Netherlands..
    Spaander, Manon C. W.
    Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands..
    Smigiel, Robert
    Wroclaw Med Univ, Dept Pediat, Div Pediat & Rare Disorders, Wroclaw, Poland..
    Patkowski, Dariusz
    Wroclaw Med Univ, Dept Pediat Surg & Urol, Wroclaw, Poland..
    Roeleveld, Nel
    Radboudumc, Dept Hlth Evidence, Radboud Inst Hlth Sci, Nijmegen, Netherlands..
    van Rooij, Iris Alm
    Radboudumc, Dept Hlth Evidence, Radboud Inst Hlth Sci, Nijmegen, Netherlands..
    de Blaauw, Ivo
    Radboudumc Amalia Childrens Hosp, Dept Surg, Pediat Surg, Nijmegen, Netherlands..
    Hoelscher, Alice
    Univ Hosp Cologne, Dept Pediat Surg & Urol, Cologne, Germany..
    Pauly, Marcus
    Asklepios Childrens Hosp St Augustin, Dept Pediat Surg, St Augustin, Germany..
    Leutner, Andreas
    Med Ctr Dortmund, Dept Pediat Surg, Dortmund, Germany..
    Fuchs, Joerg
    Univ Tubingen, Dept Pediat Surg, Childrens Hosp, Tubingen, Germany..
    Niethammer, Joel
    Univ Tubingen, Dept Pediat Surg, Childrens Hosp, Tubingen, Germany..
    Melissari, Maria-Theodora
    Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, Frankfurt, Germany..
    Jenetzky, Ekkehart
    Univ Witten Herdecke, Fac Hlth, Sch Med, Witten, Germany.;Johannes Gutenberg Univ Mainz, Dept Child & Adolescent Psychiat & Psychotherapy, Univ Med Ctr, Mainz, Germany..
    Zwink, Nadine
    Johannes Gutenberg Univ Mainz, Dept Child & Adolescent Psychiat & Psychotherapy, Univ Med Ctr, Mainz, Germany..
    Thiele, Holger
    Univ Cologne, Cologne Ctr Genom, Cologne, Germany..
    Hilger, Alina Christine
    Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany.;Univ Hosp Bonn, Bonn, Germany.;Univ Hosp Bonn, Childrens Hosp, Dept Pediat, Bonn, Germany..
    Hess, Timo
    Univ Hosp Marburg, Inst Human Genet, Marburg, Germany..
    Trautmann, Jessica
    Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany.;Univ Hosp Bonn, Bonn, Germany.;Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany..
    Marks, Matthias
    RWTH Aachen Univ Clin, Sect Neurobiol Res, Clin Neurol, Aachen, Germany.;Rhein Westfal TH Aachen, Inst Biol 2, Dept Neurobiol Res, Aachen, Germany..
    Baumgarten, Martin
    Univ Hosp Marburg, Inst Human Genet, Marburg, Germany..
    Blaess, Gaby
    Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany..
    Landen, Mikael
    Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.;Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Gothenburg, Sweden..
    Fundin, Bengt
    Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden..
    Bulik, Cynthia M.
    Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.;Univ North Carolina Chapel Hill, Dept Psychiat, Chapel Hill, NC USA.;Univ North Carolina Chapel Hill, Dept Nutr, Chapel Hill, NC USA..
    Pennimpede, Tracie
    Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany.;Queens Univ, Div Canc Biol & Genet, Kingston, ON, Canada..
    Ludwig, Michael
    Univ Bonn, Dept Clin Chem & Clin Pharmacol, Bonn, Germany..
    Ludwig, Kerstin U.
    Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany.;Univ Hosp Bonn, Bonn, Germany.;Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany..
    Mangold, Elisabeth
    Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany.;Univ Hosp Bonn, Bonn, Germany..
    Heilmann-Heimbach, Stefanie
    Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany.;Univ Hosp Bonn, Bonn, Germany.;Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany..
    Moebus, Susanne
    Univ Duisburg Essen, Univ Hosp Essen, Inst Urban Publ Hlth, Essen, Germany..
    Herrmann, Bernhard G.
    Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany..
    Alsabeah, Kristina
    Karolinska Univ Hosp, Dept Upper GI Dis, Stockholm, Sweden.;Karolinska Inst, Unit Gastroenterol & Rheumatol, Stockholm, Sweden..
    Burgos, Carmen M.
    Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.;Karolinska Univ Hosp, Dept Paediat Surg, Stockholm, Sweden..
    Engstrand Lilja, Helene
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Pediatric Surgery.
    Azodi, Sahar
    Karolinska Univ, Perioperat Med & Intens Care, Stockholm, Sweden..
    Stenstrom, Pernilla
    Skane Univ Hosp, Dept Pediat Surg, Lund, Sweden..
    Arnbjornsson, Einar
    Skane Univ Hosp, Dept Pediat Surg, Lund, Sweden..
    Frybova, Barbora
    Charles Univ Prague, Dept Paediat Surg, Fac Med 2, Prague, Czech Republic.;Motol Univ Hosp, Prague, Czech Republic..
    Lebensztejn, Dariusz M.
    Med Univ Bialystok, Dept Pediat Gastroenterol Hepatol Nutr & Allergol, Bialystok, Poland..
    Debek, Wojciech
    Med Univ Bialystok, Dept Pediat Surg & Urol, Bialystok, Poland..
    Kolodziejczyk, Elwira
    Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol Feeding Disorders & Pe, Warsaw, Poland..
    Kozera, Katarzyna
    Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol Feeding Disorders & Pe, Warsaw, Poland..
    Kierkus, Jaroslaw
    Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol Feeding Disorders & Pe, Warsaw, Poland..
    Kalicinski, Piotr
    Polish Mothers Mem Hosp Res Inst, Gastroenterol Allergol & Pediat Dept, Lodz, Poland..
    Stefanowicz, Marek
    Polish Mothers Mem Hosp Res Inst, Gastroenterol Allergol & Pediat Dept, Lodz, Poland..
    Socha-Banasiak, Anna
    Polish Mothers Mem Hosp Res Inst, Gastroenterol Allergol & Pediat Dept, Lodz, Poland..
    Kolejwa, Michal
    Polish Mothers Mem Hosp Res Inst, Gastroenterol Allergol & Pediat Dept, Lodz, Poland..
    Piaseczna-Piotrowska, Anna
    Childrens Mem Hlth Inst, Dept Pediat Surg Urol & Transplantol, Warsaw, Poland..
    Czkwianianc, Elzbieta
    Polish Mothers Mem Hosp Res Inst, Gastroenterol Allergol & Pediat Dept, Lodz, Poland..
    Noethen, Markus M.
    Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany.;Univ Hosp Bonn, Bonn, Germany.;Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany..
    Grote, Phillip
    Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, Frankfurt, Germany..
    Rygl, Michal
    Charles Univ Prague, Dept Paediat Surg, Fac Med 2, Prague, Czech Republic.;Motol Univ Hosp, Prague, Czech Republic..
    Reinshagen, Konrad
    Univ Med Ctr Hamburg Eppendorf, Dept Pediat Surg, Hamburg, Germany..
    Spychalski, Nicole
    Cnopfsche Kinderklin, Dept Pediat Surg & Urol, Nurnberg, Germany..
    Ludwikowski, Barbara
    Med Ctr Children & Adolescents 8AUF BULT, Dept Pediat Surg & Pediat Urol, Hannover, Germany..
    Hubertus, Jochen
    Ruhr Univ Bochum, Marien Hosp Witten, Dept Pediat Surg, Bochum, Germany..
    Heydweiller, Andreas
    Univ Hosp Bonn, Dept Pediat Surg, Bonn, Germany..
    Ure, Benno
    Hannover Med Sch, Ctr Pediat Surg Hannover, Hannover, Germany..
    Muensterer, Oliver J.
    Univ Med Mainz, Dept Pediat Surg, Mainz, Germany.;Ludwig Maximilians Univ LMU Munich, Dept Pediat Surg, Dr von Haunersches Kinderspital, Munich, Germany..
    Aubert, Ophelia
    Univ Leipzig, Dept Pediat Surg, Leipzig, Germany..
    Gosemann, Jan-Hendrik
    Univ Leipzig, Dept Pediat Surg, Leipzig, Germany..
    Lacher, Martin
    Univ Leipzig, Dept Pediat Surg, Leipzig, Germany..
    Degenhardt, Petra
    Ernst von Bergmann Hosp, Dept Pediat Surg, Potsdam, Germany..
    Boemers, Thomas M.
    Univ Hosp Cologne, Dept Pediat Surg & Urol, Cologne, Germany..
    Mokrowiecka, Anna
    Med Univ Lodz, Dept Digest Tract Dis, Lodz, Poland..
    Malecka-Panas, Ewa
    Med Univ Lodz, Dept Digest Tract Dis, Lodz, Poland..
    Woehr, Markus
    Univ Marburg, Behav Neurosci Expt & Biol Psychol, Marburg, Germany.;Philipps Univ Marburg, Ctr Mind Brain & Behav, Marburg, Germany.;Social & Affect Neurosci Res Grp, Lab Biol Psychol, Res Unit Brain & Cognit, Fac Psychol & Educ Sci, Leuven, Belgium.;Katholieke Univ Leuven, Leuven Brain Inst, Leuven, Belgium..
    Knapp, Michael
    Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany..
    Seitz, Guido
    Univ Childrens Hosp, Dept Pediat Surg, Marburg, Germany..
    de Klein, Annelies
    Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands..
    Oracz, Grzegorz
    Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol Feeding Disorders & Pe, Warsaw, Poland..
    Brosens, Erwin
    Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands..
    Reutter, Heiko
    Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany.;Univ Hosp Bonn, Bonn, Germany.;Univ Hosp, Dept Pediat & Adolescent Med, Div Neonatol & Pediat Intens Care, Erlangen, Germany..
    Schumacher, Johannes
    Univ Hosp Marburg, Inst Human Genet, Marburg, Germany.;Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany.;Univ Hosp Bonn, Bonn, Germany..
    First genome-wide association study of esophageal atresia identifies three genetic risk loci at CTNNA3, FOXF1/FOXC2/FOXL1, and HNF1B2022In: Human Genetics and Genomics Advances, E-ISSN 2666-2477, Vol. 3, no 2, article id 100093Article in journal (Refereed)
    Abstract [en]

    Esophageal atresia with or without tracheoesophageal fistula (EA/TEF) is the most common congenital malformation of the upper digestive tract. This study represents the first genome-wide association study (GWAS) to identify risk loci for EA/TEF. We used a European case-control sample comprising 764 EA/TEF patients and 5,778 controls and observed genome-wide significant associations at three loci. On chromosome 10q21 within the gene CTNNA3 (p = 2.11 x 10(-8); odds ratio [OR] = 3.94; 95% confidence interval [CI], 3.10-5.00), on chromosome 16q24 next to the FOX gene cluster (p = 2.25 x 10(-10); OR = 1.47; 95% CI, 1.38-1.55) and on chromosome 17q12 next to the gene HNF1B (p = 3.35 x 10(-16); OR = 1.75; 95% CI, 1.64-1.87). We next carried out an esophageal/tracheal transcriptome profiling in rat embryos at four selected embryonic time points. Based on these data and on already published data, the implicated genes at all three GWAS loci are promising candidates for EA/TEF development. We also analyzed the genetic EA/TEF architecture beyond the single marker level, which revealed an estimated single-nucleotide polymorphism (SNP)-based heritability of around 37% +/- 14% standard deviation. In addition, we examined the polygenicity of EA/TEF and found that EA/TEF is less polygenic than other complex genetic diseases. In conclusion, the results of our study contribute to a better understanding on the underlying genetic architecture of ET/TEF with the identification of three risk loci and candidate genes.

    Download full text (pdf)
    fulltext
  • 27.
    Georgantzi, Kleopatra
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Neuropediatrics/Paediatric oncology. University Children's Hospital, Uppsala, Sweden.
    Sköldenberg, Erik
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery. University Children's Hospital, Uppsala, Sweden.
    Stridsberg, Mats
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Biochemical endocrinology. University Hospital, Uppsala, Sweden.
    Kogner, Per
    Department of Women´s and Children´s Health, Karolinska University Hospital, Solna, Stockholm, Sweden.
    Jakobson, Åke
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Neuropediatrics/Paediatric oncology. University Children's Hospital, Uppsala, Sweden.
    Tiensuu Janson, Eva
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Endocrin Oncology.
    Christofferson, Rolf. H.B.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery. University Children's Hospital, Uppsala, Sweden.
    Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.2018In: Pediatric Hematology & Oncology, ISSN 0888-0018, E-ISSN 1521-0669, Vol. 35, no 2, p. 156-165Article in journal (Refereed)
    Abstract [en]

    Chromogranin A (CgA) and neuron specific enolase (NSE) are important markers in adult neuroendocrine tumors (NET). Neuroblastoma (NB) has certain neuroendocrine properties. The aim of this study was to correlate blood concentrations of CgA, chromogranin B (CgB), and NSE to prognostic factors and outcome in children with NB. Blood samples from 92 patients with NB, 12 patients with benign ganglioneuroma (GN), 21 patients with non-NB solid tumors, 10 patients with acute leukemias, and 69 healthy children, were analyzed. CgA concentrations were higher in neonates vs. children older than one month in the control group (p < 0.0001), and in neonates with NB vs. the control group (p < 0.01). CgA and NSE concentrations were higher in patients with stages 3 and 4 disease (p < 0.05 and p < 0.05), in patients having tumors with amplification of MYCN (p < 0.05 and p < 0.001), or chromosome 1 p deletion (p < 0.05 and p < 0.05). NSE correlated to the tumor size at diagnosis (p < 0.001) and to tumor related death (p < 0.01) in NB. CgA and NSE concentrations were elevated in patients with NB and especially in those with advanced disease. Both CgA and NSE correlated to genetic markers, while only NSE correlated to primary tumor size and outcome in NB. We found that CgA and NSE are clinically valuable tumor markers in NB and they merit prospective clinical evaluations as such.

    Download full text (pdf)
    fulltext
  • 28.
    Georgantzi, Kleopatra
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Neuropediatrics/Paediatric oncology.
    Sköldenberg, Erik
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Tiensuu Janson, Eva
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Endocrine Oncology.
    Jakobson, Åke
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Neuropediatrics/Paediatric oncology.
    Christofferson, Rolf
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Diagnostic Ultrasound-Guided Cutting Needle Biopsies in Neuroblastoma: a safe and efficient procedure2019In: Journal of Pediatric Surgery, ISSN 0022-3468, E-ISSN 1531-5037, Vol. 54, no 6, p. 1253-1256Article in journal (Refereed)
    Abstract [en]

    Background

    Neuroblastoma (NB) is the most common extracranial solid tumor of childhood and accounts for 15% of deaths in pediatric oncology. Apart from the clinical stage at diagnosis, molecular factors are important for the characterization of the tumor and for decision on adequate treatment. Pretreatment diagnosis and molecular profiling are based on analysis of a tumor sample, obtained either by fine needle aspiration cytology (FNAC), cutting needle biopsy or open surgical biopsy. The method used depends on local tradition and routines. Ultrasound-guided cutting needle biopsy (UCNB) has been used at the Uppsala University Hospital since 1988 for diagnosis of pediatric solid tumors.

    Procedures

    Medical records of 29 patients with NB who underwent pretreatment, diagnostic, ultrasound-guided needle biopsy were reviewed. Information extracted from the patients’ records included: age at diagnosis, gender, tumor site, clinical stage, molecular profiling made on biopsies (e.g. MYCN status, ploidy and chromosomal aberrations), and UCNB complications (i.e. bleeding, pain, or anesthesiologic complications).

    Results

    A total of 34 UCNBs were performed in the 29 patients. Repeated biopsies were done in three patients. UCNB was diagnostic in 90% (26/29). A complete molecular profiling was obtained in all UCNBs after 2008. Two patients (7%) developed a significant bleeding and two (7%) needed analgesics following UCNB. Neither infection nor tumor growth in the needle tract was observed. There were no anesthesiologic complications.

    Conclusions

    UCNB is reasonably safe in patients with NB and usually gives a sufficient amount of tumor tissue for a histological diagnosis, molecular profiling, and biobank storage.

  • 29.
    Georgantzi, Kleopatra
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Neuropediatrics/Paediatric oncology.
    Tsolakis, Apostolos V.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Endocrine Tumor Biology. Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden;Karolinska Univ Hosp Solna, CCK, Stockholm, Sweden.
    Jakobson, Åke
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Neuropediatrics/Paediatric oncology.
    Christofferson, Rolf
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Tiensuu Janson, Eva
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Endocrine Oncology.
    Grimelius, Lars
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Experimental and Clinical Oncology.
    Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma2019In: Endocrine pathology, ISSN 1046-3976, E-ISSN 1559-0097, Vol. 30, no 3, p. 173-179Article in journal (Refereed)
    Abstract [en]

    Neuroblastoma (NB), the most common extracranial cancer in childhood, exhibits neuroendocrine (NE) differentiation. Two well-established NE markers, chromogranin A (CgA) and synaptophysin (syn), are used in the histopathological diagnostics. Our aims were to explore if the NE markers synaptic vesicle protein 2 (SV2) and vesicular monoamine transporter 1 (VMAT1) and 2 (VMAT2) also are expressed in human NB and if so, evaluate their usefulness in NB histopathological diagnostics. Tumor specimens from 21 NB patients, before and/or after chemotherapy, were immunostained for CgA, syn, SV2, VMAT1, and VMAT2. Clinical data was extracted from patients' records. SV2 was highly expressed in NB, as was CgA while syn was less frequently expressed compared to the other two. Both VMATs were expressed in several NB, VMAT2 in more cases than VMAT1 and its expression was similar to syn. Chemotherapy did not affect the immunoreactivity in an obvious way. SV2 was highly expressed in NB and can thus be useful marker in NB diagnostics. VMAT1 and VMAT2 were also expressed in NB but similar to syn less reliable as tumor markers.

    Download full text (pdf)
    fulltext
  • 30.
    Gustafson, Elisabet K.
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.
    Hamad, Osama A.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Clinical Immunology.
    Deckmyn, Hans
    Katholieke Univ Leuven, IRF Life Sci, Lab Thrombosis Res, Campus Kulak Kortrijk, Kortrijk, Belgium.
    Barbu, Andreea R
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology.
    Ekdahl, Kristina N.
    Linnaeus Univ, Linnaeus Ctr Biomaterials Chem, Kalmar, Sweden.
    Nilsson, Bo
    Uppsala University, Science for Life Laboratory, SciLifeLab. Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.
    Exposure of von Willebrand Factor on Isolated Hepatocytes Promotes Tethering of Platelets to the Cell Surface2019In: Transplantation, ISSN 0041-1337, E-ISSN 1534-6080, Vol. 103, no 8, p. 1630-1638Article in journal (Refereed)
    Abstract [en]

    Background. Hepatocyte transplantation (Hctx) is a potentially attractive method for the treatment of acute liver failure and liver-based metabolic disorders. Unfortunately, the procedure is hampered by the instant blood-mediated inflammatory reaction (IBMIR), a thromboinflammatory response elicited by the vascular innate immune system, causing activation of the coagulation and complement systems and clearance of transplanted cells. Observations have also revealed platelets adhered to the surface of the hepatocytes (Hc). To establish Hctx as a clinical treatment, all factors that trigger IBMIR need to be identified and controlled. This work explores the expression of von Willebrand factor (VWF) on isolated Hc resulting in tethering of platelets. Methods. VWF on Hc was studied by flow cytometry, confocal microscopy, immunoblot, and real-time polymerase chain reaction. Interaction between Hc and platelets was studied in a Chandler loop model. Adhesion of platelets to the hepatocyte surface was demonstrated by flow cytometry and confocal microscopy. Results. Isolated Hc constitutively express VWF on their cell surface and mRNA for VWF was found in the cells. Hc and platelets, independently of coagulation formed complexes, were shown by antibody blocking studies to be dependent on hepatocyte-associated VWF and platelet-bound glycoprotein Ib alpha. Conclusions. VWF on isolated Hc causes, in contact with blood, adhesion of platelets, which thereby forms an ideal surface for coagulation. This phenomenon needs to be considered in hepatocyte-based reconstitution therapy and possibly even in other settings of cell transplantation.

  • 31.
    Gustafson, Elisabet K.
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Research group (Dept. of women´s and children´s health), Pediatric Surgery.